The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders.
about
Randomized control trial of topical clonidine for treatment of painful diabetic neuropathyEvidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and RehabilitatiEfficacy of focused low-intensity pulsed ultrasound therapy for the management of knee osteoarthritis: a randomized, double blind, placebo-controlled trialDynamic contrast-enhanced MRI serves as a predictor of HIFU treatment outcome for uterine fibroids with hyperintensity in T2-weighted images.A community pain service solution-focused pain management programme: delivery and preliminary outcome data.Analgesic and anti-hyperalgesic effects of muscle injections with lidocaine or saline in patients with fibromyalgia syndrome.Superiority of duloxetine to placebo in improving diabetic neuropathic pain: Results of a randomized controlled trial in JapanIdentifying treatment responders and predictors of improvement after cognitive-behavioral therapy for juvenile fibromyalgia.Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & RehabilitationSteroid injections added to the usual treatment of lumbar radicular syndrome: a pragmatic randomized controlled trial in general practice.Single-lead percutaneous peripheral nerve stimulation for the treatment of hemiplegic shoulder pain: a case report.Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting.Are Modic changes prognostic for recovery in a cohort of patients with non-specific low back pain?Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer.Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter studyEfficacy of Duloxetine in Patients with Chronic Pain ConditionsEfficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis.Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placeboTopical ambroxol for the treatment of neuropathic pain. An initial clinical observation.Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment System.Pain assessment using the NIH Toolbox.Personalized symptom goals and response in patients with advanced cancer.Real-life efficacy of pregabalin for the treatment of peripheral neuropathic pain in daily clinical practice in Denmark: the NEP-TUNE study.Acceptance and Commitment Therapy for chronic pain: A diary study of treatment process in relation to reliable change in disability.Temperament, Beliefs About Pain Control, and Pain Intensity in Endometriosis Patients.A pilot trial of intravenous pamidronate for chronic low back pain.Investigation of central pain processing in postoperative shoulder pain and disability.Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgiaDependence of the minimal clinically important improvement on the baseline value is a consequence of floor and ceiling effects and not different expectations by patients.Pain and Physical Functioning in Neuropathic Pain: A Systematic Review of Psychometric Properties of Various Outcome Measures.Choosing drugs for the treatment of diabetic neuropathy.Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials.The effectiveness of a cognitive behavioral exercise approach (CBEA) compared to usual care in patients with a Whiplash associated disorder: A quasi-experimental clinical trial.Using a New Measurement to Evaluate Pain Relief Among Cancer Inpatients with Clinically Significant Pain Based on a Nursing Information System: A Three-Year Hospital-Based Study.Correlation between pain response and improvements in patient-reported outcomes and health-related quality of life in duloxetine-treated patients with diabetic peripheral neuropathic pain.Treatment of chronic lumbosacral radicular pain using adjuvant pulsed radiofrequency: a randomized controlled study.Assessing the response to opioids in cancer patients: a methodological proposal and the results.How to evaluate the effect of pain treatments in cancer patients: results from a longitudinal outcomes and endpoint Italian cohort study.Clinical efficacy of aconitum-containing traditional Chinese medicine for diabetic peripheral neuropathic pain.The COMFORT behaviour scale detects clinically meaningful effects of analgesic and sedative treatment.
P2860
Q24621657-2B2CB889-13E0-471F-B050-B02FA48C067CQ24632313-64D18954-8A44-4614-B7EE-7F7EFC1ABD74Q30371835-7D368BEE-53EF-4BF8-AFE8-B1F783C6BBCDQ30390864-F6CF8F81-C4AA-49C0-A97C-17300C94A063Q31013332-98FB9319-6A92-4D81-B9D5-1128E4B7C635Q33568337-94462C2C-A175-4682-B673-EF49103DE92AQ33588319-80655A2D-95A6-4768-A7FB-A826F0C426DBQ33758444-689E908C-5023-4F9B-A0EA-08943090750AQ33870062-B905D141-CD2E-4955-A6C7-383FF232CC28Q34355507-2E2BD762-8160-49AF-87BA-B71CD44DA07EQ34914338-BC879FC3-C284-4BCB-93CC-AADFDC289BDAQ35548185-DF77249D-9288-4C10-A52C-EA38C57BAF5BQ35812714-E98F4861-BD6D-4234-845E-66404CD66E7AQ35925132-CE529569-9A71-493B-B0B5-3F6DD6969D33Q36126617-ADC7A6E6-5F39-492F-81BE-D55D0CAE484BQ36141335-EC6A91B1-DA3E-4255-8807-1DE7D43BC141Q36257042-D44ED4E8-8818-40B6-869E-818EA3DD143BQ36380212-64F5FA17-C81D-400E-8917-89703CE5ECB8Q36431418-D84E7F84-986C-4CFC-B9E6-36E55A72A94FQ36522629-A5EC870E-D7B3-48D8-96A2-B7A8C6687D0BQ36870220-2AA5669D-30BD-4AEE-B03B-507A0F02E840Q36918198-D09386D5-7379-4B2B-8B56-4571BB3F98E4Q36940081-EDBCBEEC-25A6-401E-A6D8-1174055BEB13Q37395406-968C2630-1CCF-41A5-B3DA-03EA05548C2EQ37459430-A38CA7D7-927B-4B92-AC01-54B264AC427FQ37626310-CD4CBDE6-3665-49AB-B55D-793B22A26410Q37638511-92C85518-5A56-496B-82E3-BFAA372B9ABAQ37690358-6B8E0AF3-49A6-427B-9CF1-03D31AC0AA2FQ37732454-512A5B5A-4BD3-4706-826D-E5FCBBBF55BDQ38417354-5568894B-C0CB-4A60-8F0F-6B945AFEB440Q38544804-57983C66-C46C-4E33-B13F-A20668E383B5Q38645778-F28ECD8B-483B-4BFD-9381-DA73EDFFEB0CQ38689778-3FE844B5-8FE0-4134-82DB-02F44FF0208CQ39175055-A685B727-2BFC-45A8-934C-218C53B7144BQ39184195-583D60D7-AD25-4419-AF66-B03CBA4DD546Q39196869-798C6153-DE0C-4C24-B576-FDF947DAFD2EQ39197627-09E4CC99-367E-4970-9375-499EDF3307AFQ39236819-E227E89F-E2D8-4E08-B00C-A70D130CAECFQ39263101-697E8BAA-A7F3-4E43-945B-6268AD68C730Q40210765-5A4EE6F7-2684-4183-82D7-9BE5E7FC846C
P2860
The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The clinical importance of cha ...... duloxetine in pain disorders.
@ast
The clinical importance of cha ...... duloxetine in pain disorders.
@en
type
label
The clinical importance of cha ...... duloxetine in pain disorders.
@ast
The clinical importance of cha ...... duloxetine in pain disorders.
@en
prefLabel
The clinical importance of cha ...... duloxetine in pain disorders.
@ast
The clinical importance of cha ...... duloxetine in pain disorders.
@en
P2093
P1433
P1476
The clinical importance of cha ...... duloxetine in pain disorders.
@en
P2093
Amy Chappell
Apurva Prakash
John T Farrar
Michael Robinson
Yili L Pritchett
P304
P356
10.1016/J.JPAIN.2009.06.007
P577
2009-08-08T00:00:00Z